- Home
- HONE vs REPL Comparison
HONE vs REPL Comparison
Compare HONE & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HONE
- REPL
- Stock Information
- Founded
- HONE 1917
- REPL 2015
- Country
- HONE United States
- REPL United States
- Employees
- HONE N/A
- REPL N/A
- Industry
- HONE Major Banks
- REPL Biotechnology: Pharmaceutical Preparations
- Sector
- HONE Finance
- REPL Health Care
- Exchange
- HONE Nasdaq
- REPL Nasdaq
- Market Cap
- HONE 513.0M
- REPL 547.0M
- IPO Year
- HONE 2016
- REPL 2018
- Fundamental
- Price
- HONE $12.69
- REPL $5.67
- Analyst Decision
- HONE Buy
- REPL Buy
- Analyst Count
- HONE 3
- REPL 10
- Target Price
- HONE $14.50
- REPL $8.25
- AVG Volume (30 Days)
- HONE 183.7K
- REPL 17.2M
- Earning Date
- HONE 07-24-2025
- REPL 08-07-2025
- Dividend Yield
- HONE 2.98%
- REPL N/A
- EPS Growth
- HONE 71.76
- REPL N/A
- EPS
- HONE 0.65
- REPL N/A
- Revenue
- HONE $164,819,000.00
- REPL N/A
- Revenue This Year
- HONE N/A
- REPL N/A
- Revenue Next Year
- HONE $9.44
- REPL $194.05
- P/E Ratio
- HONE $18.62
- REPL N/A
- Revenue Growth
- HONE N/A
- REPL N/A
- 52 Week Low
- HONE $8.89
- REPL $2.68
- 52 Week High
- HONE $13.73
- REPL $17.00
- Technical
- Relative Strength Index (RSI)
- HONE 67.29
- REPL 45.73
- Support Level
- HONE $11.87
- REPL $5.08
- Resistance Level
- HONE $12.29
- REPL $5.84
- Average True Range (ATR)
- HONE 0.23
- REPL 0.46
- MACD
- HONE 0.05
- REPL 0.17
- Stochastic Oscillator
- HONE 100.00
- REPL 62.11
About HONE HarborOne Bancorp Inc.
HarborOne Bancorp Inc is a bank holding company. The company is engaged in providing financial services like accepting deposits, lending loans, online and mobile banking, cash management, credit cards, money market accounts, and wealth management. The Company has two reportable segments: HarborOne Bank and HarborOne Mortgage. The bank provides financial services to individuals and businesses online and through its full-service branches located in Massachusetts and Rhode Island, one limited-service branch, and a commercial lending office in Boston, Massachusetts, and Providence, Rhode Island.
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.